Taoli Sun
- Pharmacology top 2%
- Hops Chemistry and Applications 4
- Pharmacological Effects of Natural Compounds 2
- Biochemistry top 10%
-
- PI3K/AKT/mTOR signaling in cancer 3
- Natural product bioactivities and synthesis 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 7
-
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 2
-
- Antioxidants, Aging, Portulaca oleracea 2
Taoli Sun
27 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pharmacology 216
- Aging 17
- Complementary and alternative medicine 74
- Biochemistry 50
- Molecular Biology 479
Countries citing papers authored by Taoli Sun
This map shows the geographic impact of Taoli Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taoli Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taoli Sun more than expected).
Fields of papers citing papers by Taoli Sun
This network shows the impact of papers produced by Taoli Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taoli Sun. The network helps show where Taoli Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taoli Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 12 | |
| 10 | 2022 | 28 | |
| 11 | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitisbreakdown → | 2021 | 164 |
| 12 | 2021 | 6 | |
| 13 | 2021 | 58 | |
| 14 | 2020 | 77 | |
| 15 | 2020 | 113 | |
| 16 | 2020 | 52 | |
| 17 | 2019 | 30 | |
| 18 | 2019 | 76 | |
| 19 | 2018 | 197 | |
| 20 | 2018 | 48 |
About Taoli Sun
Taoli Sun is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Oncology, Analytical Chemistry and Cancer Research, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Hops Chemistry and Applications (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Treatment and Pharmacology (3 papers), Antioxidants, Aging, Portulaca oleracea (2 papers), Natural product bioactivities and synthesis (2 papers), Peptidase Inhibition and Analysis (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Pharmacology (216 citations), Aging (17 citations), Complementary and alternative medicine (74 citations), Biochemistry (50 citations) and Molecular Biology (479 citations). Taoli Sun has collaborated with scholars based in China. Frequent co-authors include Shanshan Wei, Bikui Zhang, Wenqun Li, Chuanhao Jiang, Wen‐Qun Li, Daxiong Xiang, Wanjun Ma, Xiaoliang Tong, Jiaqin Liu and Weijun Peng. Their work appears in journals such as Drug Design Development and Therapy, European Journal of Pharmacology, Biochemical Pharmacology, Phytomedicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.